{
    "deliberation_results": {
        "Influenza Surveillance (CDC Influenza Risk Assessment Tool)": {
            "time_to_resolution": "Approximately 2.5 months (forecast date: 2025-10-15; resolution: 2026-01-01)",
            "perspective_relevance": "As an expert in influenza surveillance and the CDC's Influenza Risk Assessment Tool (IRAT), I understand the detailed criteria that drive the IRAT's 'emergence' risk categorization, the weighting of risk elements, and the historical thresholds for escalation to 'high' risk. My expertise allows me to rigorously assess the significance of recent virological, epidemiological, and surveillance developments, and distinguish between real-world emergence risk and public/media alarm. I can leverage both base rates of IRAT score movement and the technical underpinnings of risk scoring.",
            "status_quo": "No H5 virus has ever received a 'high' (>=8.0) emergence risk rating from the IRAT. The most recent H5N1 IRAT emergence risk score (as of August 9, 2024) is 5.79, which is solidly in the 'moderate' range (4.0\u20137.9). Historically, IRAT scores for H5 viruses have remained in the moderate range despite periodic animal outbreaks and zoonotic spillovers.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent zoonotic cases and mammalian adaptation",
                    "effect": "Increases probability modestly. Multiple human H5N1 cases have occurred in the US (70 as of late 2025, mostly mild, one fatality) and the virus has infected cattle, cats, and other mammals. Studies have identified mutations (PB2-478I, NP-450N) that increase mammalian virulence. However, evidence for sustained human-to-human transmission is lacking, and most cases are occupational exposures."
                },
                {
                    "factor": "IRAT scoring inertia and historical base rate",
                    "effect": "Decreases probability. IRAT scores move slowly and conservatively. Despite significant animal and sporadic human H5N1 outbreaks in recent years, scores have not approached 'high.' The IRAT panel is cautious and typically requires clear evidence of increased human-to-human transmission (e.g., clusters, efficient airborne transmission in ferrets, or major changes in receptor binding) to move into the high-risk range."
                },
                {
                    "factor": "Virological findings: mutations and transmission studies",
                    "effect": "Increases probability slightly. Recent research has identified mutations that increase virulence and mammalian adaptation, but airborne transmission between ferrets (a critical IRAT risk element) has not been demonstrated. The virus retains avian-like properties, and receptor-binding assays still show a preference for avian (not human) receptors. This keeps the overall emergence risk moderate."
                },
                {
                    "factor": "Risk element scoring: human infections, animal model transmission, genomic analysis",
                    "effect": "Mostly neutral to slightly increasing. While there have been more zoonotic infections and some concerning mutations, none of the nine IRAT risk elements have individually moved the weighted score above the moderate range. The absence of efficient and sustained human-to-human spread, and only rare unexplained zoonoses (like the California child), keeps the emergence score anchored below 8.0."
                },
                {
                    "factor": "Global and CDC risk communication",
                    "effect": "Decreases probability. Both the CDC and international agencies (WHO, FAO, OIE) continue to rate the public risk as low to moderate, and stress that no evidence of efficient human-to-human transmission exists. The IRAT process is tightly coupled to these agencies' surveillance and interpretation."
                },
                {
                    "factor": "Window to resolution (time constraint)",
                    "effect": "Decreases probability. With less than three months to go, there would need to be a dramatic virological or epidemiological development (e.g., demonstrated human-to-human transmission, a large unexplained cluster, or major reassortment event) for the IRAT to update to 'high' risk. Such events are rare and tend to be reported rapidly if they occur."
                }
            ],
            "no_scenario": "H5N1 continues to circulate in animals and causes sporadic zoonotic cases (mostly mild, mostly linked to direct animal contact), but there is no evidence of efficient human-to-human transmission or major viral reassortment. The IRAT panel updates the score but keeps it in the moderate range (<8.0), citing lack of key criteria (especially transmission studies and epidemiology). The question resolves 'No.'",
            "yes_scenario": "A major, well-documented outbreak of H5N1 occurs with evidence of sustained human-to-human transmission (e.g., a large cluster without animal exposure; confirmed airborne transmission in ferrets in updated peer-reviewed studies; or a new viral genotype with clear mammalian receptor binding and transmission), prompting the IRAT panel to rapidly convene and update the emergence risk score to 8.0 or higher before January 1, 2026. The question resolves 'Yes.'",
            "final_reasoning": "Despite notable developments in H5N1 epidemiology\u2014mammalian infections, some zoonotic spillover, and identification of mammalian-adaptive mutations\u2014the IRAT's 'high' emergence risk threshold is unlikely to be crossed imminently. The risk score has shown strong inertia, and no public evidence exists of efficient, sustained human-to-human transmission or a major viral breakthrough. The CDC and international agencies continue to message 'low to moderate' risk, and the IRAT panel is conservative in score escalation. With under three months left and in the absence of an unprecedented event, a jump to 8.0+ is unlikely. I therefore assign a probability close to the historical base rate, with a modest upward adjustment for the increased frequency of zoonoses and mammalian adaptation, but still heavily weighted toward 'No.'",
            "final_probability": 6
        },
        "Veterinary Medicine (Zoonotic Spillover Assessment)": {
            "time_to_resolution": "Approximately 2.5 months (until January 1, 2026)",
            "perspective_relevance": "As a veterinary medicine expert specializing in zoonotic spillover, I focus on how animal pathogens, especially influenza A viruses like H5N1, adapt and threaten human populations. I bring an understanding of host range shifts, viral evolution, animal surveillance, cross-species transmission, and historical pandemic emergence, which are central to IRAT's 'emergence' risk calculation.",
            "status_quo": "The IRAT has never issued a 'high' (>=8.0) emergence risk rating for any H5 virus. The latest H5N1 emergence score is 5.79 (moderate), and all recent IRAT updates, as of August 2024, indicate moderate risk. H5N1 continues to cause concern due to mammalian adaptation, but no sustained human-to-human transmission has occurred.",
            "perspective_derived_factors": [
                {
                    "factor": "Host range expansion to mammals, especially dairy cattle",
                    "effect": "Increases probability, as unprecedented infections in cattle suggest enhanced mammalian adaptation and more opportunities for reassortment or further adaptation."
                },
                {
                    "factor": "Genetic mutations associated with mammalian adaptation (PB2\u2011478I, NP\u2011450N)",
                    "effect": "Increases probability, as these mutations enhance replication in mammals and are directly linked to increased virulence in ferrets, a key IRAT animal model."
                },
                {
                    "factor": "Current epidemiological data: human cases and transmission",
                    "effect": "Decreases probability, as nearly all documented US human H5N1 cases (70 cases, 1 death) are mild, sporadic, and lack evidence of human-to-human transmission\u2014the key threshold for 'high' emergence risk."
                },
                {
                    "factor": "IRAT methodology and historical conservatism",
                    "effect": "Decreases probability. The IRAT is slow to upgrade risk unless there is clear evidence of efficient and sustained human-to-human spread or a major genetic leap; even with significant animal outbreaks and mutations, the CDC has not previously rated H5 above moderate."
                },
                {
                    "factor": "International and US public health response and surveillance",
                    "effect": "Decreases probability. Enhanced surveillance, rapid containment, and existing vaccine/antiviral stockpiles reduce the likelihood that CDC will perceive an imminent risk of emergence warranting a 'high' rating."
                },
                {
                    "factor": "Potential for laboratory escape or gain-of-function research",
                    "effect": "Slightly increases probability, as new reports of synthetic or chimeric influenza viruses and ongoing gain-of-function research increase theoretical risk of a sudden leap in emergence potential, but there is no evidence of such an event to date."
                },
                {
                    "factor": "Base rates and status quo inertia",
                    "effect": "Strongly decreases probability. No H5 virus has reached 'high' emergence risk in IRAT history, and viral adaptation to humans is typically incremental, requiring both critical mutations and epidemiological evidence."
                }
            ],
            "no_scenario": "Despite ongoing outbreaks in birds, cattle, and occasional mammalian spillovers, H5N1 remains mostly an avian and sporadic zoonotic pathogen. Human cases continue to be rare and non-sustained. The CDC monitors, but IRAT scores for H5 viruses remain in the moderate range (<8.0), as no clear evidence of efficient human-to-human transmission or major genetic shift emerges before January 1, 2026.",
            "yes_scenario": "A sudden cluster of human H5N1 cases appears, possibly among people with minimal animal contact, and onward human-to-human transmission is confirmed, perhaps supported by a new, high-risk mutation detected in the virus. Animal models show airborne transmission, and/or a lab escape event occurs, causing the CDC to urgently update the IRAT 'emergence' score for an H5 virus to 8.0 or above.",
            "final_reasoning": "While H5N1 has taken concerning steps toward mammalian adaptation, with notable mutations and bovine outbreaks, the CDC IRAT's scoring history and methodology are conservative and heavily weigh real-world human transmission. Despite theoretical risks from recent genetic changes and gain-of-function research, there is no current evidence of efficient human-to-human spread. Only 70 mild US human H5N1 cases have been detected, most with clear animal exposure, and no sustained chains of transmission. The IRAT has never rated H5 emergence risk as high in its history, and the most recent (Aug 2024) score is 5.79, with little time left for a major change barring a dramatic epidemiological or virological event. Base rates and status quo bias both suggest a low probability of a 'high' score being issued before January 1, 2026.",
            "final_probability": 7
        },
        "Global Health Security (International Health Regulations)": {
            "time_to_resolution": "Approximately 2.5 months (question resolves January 1, 2026; today is October 15, 2025).",
            "perspective_relevance": "As a Global Health Security expert specializing in International Health Regulations (IHR), I closely monitor not just virological and epidemiological data, but also the surveillance, risk assessment, and regulatory decision-making processes at CDC and their interplay with international agencies like WHO and OIE. The IRAT's 'emergence' risk rating is a function of both biological data and institutional caution, making it critical to understand both the scientific trajectory of H5 viruses and the organizational thresholds for declaring high emergence risk. My expertise allows me to contextualize current H5N1 events within the broader landscape of historical zoonotic threats and the CDC's risk communication norms.",
            "status_quo": "As of August 9, 2024, the highest documented IRAT emergence risk score for any H5 virus is 5.79 (moderate), well below the 'high' threshold (\u22658.0). No H5 virus has ever received a 'high' emergence risk rating by CDC IRAT. Historically, CDC has been conservative in moving viruses into the 'high' category unless clear, sustained human-to-human transmission or major adaptive changes are observed.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent mammalian adaptation and human spillover events",
                    "effect": "Increases probability modestly. The detection of North American H5N1 with mammalian-adaptive mutations (PB2-478I and NP-450N), its unprecedented spread in cattle, and 70 confirmed U.S. human cases (mostly mild) demonstrate increased zoonotic potential and cross-species transmission, which are central to IRAT's emergence risk calculation."
                },
                {
                    "factor": "Absence of sustained human-to-human transmission",
                    "effect": "Decreases probability. Despite increased mammalian infections, there are no confirmed cases of efficient or sustained human-to-human transmission, as emphasized by CDC, WHO, and international agencies. This is a critical threshold for CDC to rate emergence risk as 'high'."
                },
                {
                    "factor": "Short time frame to resolution (2.5 months)",
                    "effect": "Decreases probability. There is limited time for a dramatic shift in risk profile, such as a major adaptive event or cluster of sustained human transmission, to occur, be detected, and have the CDC convene an IRAT assessment and publish an updated score."
                },
                {
                    "factor": "Institutional caution and communication norms",
                    "effect": "Decreases probability. The CDC has a high bar for rating pandemic emergence risk as 'high' given the ramifications for public health preparedness, funding, and public messaging. Even with concerning developments, CDC tends to move incrementally unless there is overwhelming evidence."
                },
                {
                    "factor": "Global and U.S. surveillance and response capacity",
                    "effect": "Decreases probability. The U.S. and global partners are actively surveilling, sequencing, and responding to H5 events. While there is concern about gaps, the overall system is robust, making it less likely that a major emergence event would go unnoticed or unassessed for long, but also less likely that the CDC would preemptively escalate the risk rating absent clear evidence."
                },
                {
                    "factor": "Potential for sudden viral evolution or reassortment",
                    "effect": "Increases probability slightly. While rare, influenza viruses can evolve rapidly, especially with extensive circulation in multiple mammalian hosts. A reassortment event (e.g., with swine flu) could theoretically trigger a rapid risk escalation if detected."
                }
            ],
            "no_scenario": "Despite ongoing H5N1 outbreaks in birds, cattle, and occasional spillover to humans (mostly mild, no onward transmission), the virus does not acquire mutations enabling efficient human-to-human transmission. The CDC monitors closely, but IRAT scores remain in the moderate range, reflecting increasing concern but not crossing the 'high' threshold. No new IRAT assessment is published with a score of \u22658.0 for H5 viruses by January 1, 2026.",
            "yes_scenario": "Within the next 2.5 months, there is a major epidemiological event\u2014such as a cluster of human H5N1 cases with evidence of sustained human-to-human transmission, or clear virological evidence of critical adaptive mutations (e.g., switch in receptor binding preference with associated epidemiological evidence)\u2014prompting the CDC to rapidly reassess and publish an IRAT emergence risk score in the 'high' range (\u22658.0), for at least one H5 virus.",
            "final_reasoning": "The CDC IRAT has never rated an H5 virus as 'high' (emergence risk \u22658.0). While the North American H5N1 clade 2.3.4.4b has acquired mutations increasing virulence in mammals and has led to an unprecedented number of mammalian (bovine, feline, and occasional human) infections, there is no evidence to date of efficient human-to-human transmission, which is the critical driver for escalation to 'high' emergence risk. All recent CDC and WHO risk assessments continue to characterize the public risk as 'low', and the most recent IRAT score for H5N1 (5.79) remains solidly in the moderate category. Although the virus's adaptation to mammals is concerning and ongoing surveillance is warranted, the short time frame makes it unlikely that both a major biological shift and an updated CDC IRAT assessment (with a public announcement of \u22658.0) will occur before January 1, 2026. The base rate for H5 viruses moving to 'high' is effectively zero, and recent developments, while worrisome, do not meet the historical or institutional threshold for a rapid leap to 'high' emergence risk. The most likely outcome is continued moderate concern, with perhaps increased CDC messaging and preparedness, but no official 'high' IRAT rating.",
            "final_probability": 7
        },
        "Epidemiology (Infectious Disease Emergence Theory)": {
            "time_to_resolution": "About 2.5 months (from October 15, 2025 to December 31, 2025)",
            "perspective_relevance": "As an expert in infectious disease emergence theory, I bring a deep understanding of the ecological, evolutionary, and epidemiological drivers that enable animal influenza viruses to adapt for human-to-human transmission. My expertise allows for nuanced evaluation of viral genetic changes, surveillance data, cross-species transmission dynamics, and the real-world thresholds that would prompt an upgrade to 'high' emergence risk in the CDC IRAT.",
            "status_quo": "As of August 9, 2024, the highest IRAT emergence risk score for any H5 virus was 5.79, firmly within the 'moderate' risk range. No H5 virus has ever scored 'high' (8.0+) for emergence risk. The IRAT has not rapidly upgraded H5 emergence risk during previous waves of concern, favoring a conservative, evidence-based approach.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent mammalian adaptation and increased host range (H5N1 clade 2.3.4.4b in cattle, cats, humans)",
                    "effect": "Increases probability. The virus's demonstrated capacity to infect new mammalian hosts\u2014including dairy cattle, cats, and rare human cases\u2014shows evolutionary steps toward broader host adaptation, a key precondition for emergence risk escalation."
                },
                {
                    "factor": "Genetic findings: identification of PB2\u2011478I and NP\u2011450N mutations increasing mammalian pathogenicity",
                    "effect": "Increases probability. These mutations, proven to increase replication and virulence in mammals, are significant red flags for emergence potential, especially if found in lineages detected in humans."
                },
                {
                    "factor": "Transmission dynamics: lack of sustained human-to-human transmission",
                    "effect": "Decreases probability. Despite increased animal cases and rare human spillovers (70 US cases, mostly mild, with one death), there is still no evidence of efficient, sustained human-to-human transmission, which is a critical IRAT criterion for 'high' emergence risk."
                },
                {
                    "factor": "CDC/WHO risk assessments and response inertia",
                    "effect": "Decreases probability. Both the CDC and global agencies (WHO, FAO, OIE) currently consider the public risk to be low, and the IRAT has historically updated risk ratings slowly, requiring clear, sustained signals before assigning 'high' emergence risk."
                },
                {
                    "factor": "Global surveillance and detection capacity",
                    "effect": "Neutral or slight increase. Surveillance has improved, so a rapid, clear signal of adaptation could be detected and prompt IRAT re-evaluation. However, no such jump has occurred yet."
                },
                {
                    "factor": "Time remaining to resolution (2.5 months)",
                    "effect": "Decreases probability. With such a short window, the likelihood of a major shift in IRAT scoring\u2014given the CDC's methodical process and the current slow trend\u2014is reduced."
                }
            ],
            "no_scenario": "Despite ongoing H5N1 outbreaks in animals and occasional human spillover, there is no evidence of efficient human-to-human transmission, no sudden accumulation of key mammalian-adaptive mutations in strains infecting people, and the CDC continues to rate emergence risk as 'moderate' or lower for all H5 viruses through December 2025. IRAT updates, if any, remain cautious and reflect the slow, incremental pace seen in past years.",
            "yes_scenario": "A sudden cluster of human H5N1 cases with evidence of sustained human-to-human transmission emerges in a high-surveillance setting (e.g., the US, Europe, or East Asia), and genomic sequencing identifies the presence of PB2\u2011478I, NP\u2011450N, or other hallmark mammalian-adaptive mutations in these strains. The CDC, responding to this unprecedented risk, rapidly re-evaluates the IRAT score and, based on multiple risk elements (human infections, animal model transmission, receptor binding, etc.), assigns an 'emergence' score of 8.0 or higher to an H5 virus before the end of 2025.",
            "final_reasoning": "The status quo for IRAT H5 emergence risk is moderate, trending slowly upward but not near the 'high' threshold. While notable developments have occurred\u2014mammalian spillover, key mutations, and rare unexplained human cases\u2014there is still no clear signal of human-to-human transmission or explosive adaptation, which are crucial for IRAT to score 'high' on emergence risk. The CDC and international agencies remain publicly cautious, with no indication of imminent IRAT escalation. With only 2.5 months left and the IRAT's history of slow, conservative updates, the probability that an H5 virus will receive a 'high' emergence risk rating before January 1, 2026 is low but not negligible, due to the non-zero chance of a sudden, dramatic epidemiological shift. My estimate is therefore 8%, reflecting a base rate near zero but modestly increased by recent mammalian adaptation and genetic findings.",
            "final_probability": 8
        },
        "Epidemiology (One Health Approach)": {
            "time_to_resolution": "Approximately 2.5 months (forecast date: 2025-10-15; resolution by 2026-01-01)",
            "perspective_relevance": "As an epidemiologist specializing in the One Health approach, I integrate human, animal, and environmental data for emerging zoonoses. My expertise is particularly relevant for H5N1 risk: the virus is currently spreading across species (birds, cattle, mammals), and the IRAT's 'emergence' rating depends heavily on cross-species adaptation, genomic changes, and sustained mammalian/human transmission\u2014areas where the One Health perspective uniquely informs base rates, surveillance gaps, and risk signals.",
            "status_quo": "No H5 virus has ever received an IRAT 'high' (>=8.0) emergence risk rating. The latest (August 2024) H5N1 IRAT emergence risk score is 5.79 (upper-moderate), with no recent evidence of efficient human-to-human transmission.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent cross-species spillover and mammalian adaptation",
                    "effect": "Increases probability. H5N1 has infected cattle, cats, and isolated human cases; recent studies identified two mutations (PB2-478I and NP-450N) that increase replication and virulence in mammals. The One Health approach highlights the significance of bovine outbreaks and mammalian spillover as potential precursors to further adaptation."
                },
                {
                    "factor": "Absence of sustained human-to-human transmission",
                    "effect": "Decreases probability. Despite spillover events, there is no confirmed onward human-to-human transmission in the US or globally, and most human cases have been mild or linked to direct animal contact. The IRAT emergence score heavily weights this criterion."
                },
                {
                    "factor": "Recent increases in surveillance, biosecurity, and One Health response",
                    "effect": "Decreases probability. Heightened surveillance in cattle and poultry, along with improved biosecurity, reduces the risk of undetected adaptation or large-scale reassortment events, at least in the short term."
                },
                {
                    "factor": "Genomic and epidemiological constraints",
                    "effect": "Decreases probability. The IRAT has not rated any H5 virus as 'high emergence risk' in over a decade, despite continual animal outbreaks and some adaptive mutations. The threshold for 'high' is very conservative, and the CDC would require clear evidence of increased human transmission potential."
                },
                {
                    "factor": "Time left to resolution",
                    "effect": "Decreases probability. With only 2.5 months left, significant biological and epidemiological changes (e.g., truly efficient human transmissibility) are unlikely to be detected, scored, and published by the CDC before January 1, 2026."
                },
                {
                    "factor": "Potential for reassortment and unpredictability",
                    "effect": "Slightly increases probability. The H5N1 situation is evolving, with ongoing risk of reassortment with swine or human influenza viruses, which could rapidly change the risk calculus. However, such events are rare and would have to be both detected and scored within the narrow time window."
                }
            ],
            "no_scenario": "Despite continued H5N1 activity in wild birds, cattle, and sporadic human cases, there is no evidence of efficient or sustained human-to-human transmission. The CDC reviews new data but finds that the overall emergence risk remains 'moderate' (score <8.0) due to lack of key epidemiological or genomic breakthroughs. The IRAT is not updated to 'high' for any H5 virus before January 2026.",
            "yes_scenario": "A sudden cluster of human H5N1 cases with evidence of limited human-to-human transmission is detected (e.g., in a farm or healthcare setting), or a new H5N1 variant emerges with mutations associated with efficient mammalian transmission (e.g., airborne spread in ferrets). The CDC rapidly updates the IRAT, and the emergence risk score for at least one H5 virus is revised to 8.0 or higher before January 2026.",
            "final_reasoning": "The base rate for an H5 virus receiving a 'high' IRAT emergence rating is zero\u2014no precedent exists. Despite recent worrisome developments (cattle outbreaks, mammalian adaptation, two key mutations), the most recent CDC IRAT score remains in the mid-moderate range (5.79), and there is no evidence of efficient human-to-human transmission. The CDC and global agencies (WHO, FAO, OIE) continue to rate the public health risk as low, with only occupationally exposed individuals at moderate risk. Although the One Health perspective highlights the risk of sudden jumps in emergence risk due to cross-species transmission and potential reassortment, the time left to resolution (2.5 months) is very short\u2014meaning a dramatic biological change, its detection, CDC review, and IRAT update would all have to occur before January 1, 2026. Surveillance and biosecurity are heightened, and while the situation is dynamic, the status quo (no H5 virus reaching 'high' emergence risk) is strongly favored. Therefore, while the tail risk is non-zero, the probability remains low but not negligible given the current context.",
            "final_probability": 7
        },
        "Virology (Influenza Virus Evolution Models)": {
            "time_to_resolution": "2.5 months (until January 1, 2026)",
            "perspective_relevance": "As an expert in influenza virus evolution models, I closely track molecular determinants of host adaptation, surveillance trends, and the thresholds required for risk reclassification. My perspective is especially relevant because the IRAT 'emergence' score is a synthetic measure, heavily influenced by virological, epidemiological, and evolutionary signals from both lab and field data. Understanding which mutations, transmission patterns, and model outputs would trigger a risk upgrade is central to assessing the likelihood of a high emergence score for H5 viruses.",
            "status_quo": "Historically, the IRAT emergence risk score for H5 viruses has remained in the moderate range (latest: 5.79 as of August 2024 for H5N1), with no H5 virus ever being rated 'high' (\u22658.0). The CDC and global health agencies currently rate the public risk as low, despite ongoing animal outbreaks.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent adaptive mutations in North American H5N1 (PB2-478I, NP-450N)",
                    "effect": "Increases probability. These mutations are shown to enhance mammalian virulence and replication, raising theoretical emergence potential, but so far have not resulted in sustained human transmission."
                },
                {
                    "factor": "Human case epidemiology (number, transmission, severity)",
                    "effect": "Decreases probability. Despite ~70 human cases in the US, most are mild and none have shown clear human-to-human transmission; CDC and WHO continue to rate public risk as low."
                },
                {
                    "factor": "IRAT scoring inertia and base rate",
                    "effect": "Strongly decreases probability. In the IRAT's decade-plus history, no animal-origin virus has been rated 'high' for emergence risk, reflecting institutional conservatism and high thresholds for reclassification."
                },
                {
                    "factor": "Recent lab evidence and surveillance (ferret studies, bovine outbreaks, environmental sampling)",
                    "effect": "Slightly increases probability. Laboratory studies show increased virulence and contact transmission in mammals, and cattle outbreaks highlight cross-species jump, but airborne transmission (key for pandemic risk) remains unconfirmed."
                },
                {
                    "factor": "Pressure from One Health, CDC, WHO, and heightened surveillance",
                    "effect": "Minor increase. Heightened cross-sectoral attention and new data (e.g., environmental, untraceable human cases) could prompt a risk reassessment if evidence of adaptation emerges."
                },
                {
                    "factor": "Reassortment potential with swine/seasonal influenza",
                    "effect": "Minimal short-term effect. While theoretically increasing risk, there is no evidence of such events driving emergence within the next 2.5 months."
                }
            ],
            "no_scenario": "The IRAT maintains its current scoring, with the H5N1 emergence risk remaining in the moderate range. There are no confirmed clusters of sustained human-to-human transmission, and new surveillance data\u2014while concerning for animal health\u2014do not provide sufficient evidence of imminent adaptation or increased human risk to prompt a reclassification to 'high'. CDC and WHO continue to describe the risk as low to moderate, and the IRAT report for 2025 closes with H5 viruses below the 8.0 threshold.",
            "yes_scenario": "A marked change in epidemiology occurs\u2014e.g., a cluster of human cases with evidence for limited human-to-human transmission, or a new surveillance report demonstrates clear molecular adaptation in H5N1 (such as additional mammalian-adaptive mutations or reassortment with a human virus), prompting the CDC IRAT panel to urgently reassess and upgrade the emergence risk score to 8.0 or above before the end of 2025.",
            "final_reasoning": "The IRAT's historical conservatism and the absence of sustained human transmission or major new adaptation events in H5 viruses strongly favor the status quo. While recent mutations (PB2-478I, NP-450N) and expanded mammalian outbreaks are worrisome and slightly raise the probability of future reassessment, these have not yet resulted in the epidemiological or experimental evidence needed to push the emergence risk score into 'high' territory. The CDC, WHO, and EFSA all currently signal low to moderate risk, citing the lack of efficient human-to-human transmission. As an influenza evolution modeler, I see the theoretical risk growing, but not at a pace or with the concrete evidence required for a rapid IRAT score jump within the next 2.5 months. The base rate of IRAT 'high' ratings for H5 is zero, and only a major, clear, and unprecedented event would likely overcome the tool's scoring inertia on such a short timeline.",
            "final_probability": 8
        },
        "Virology (Host Adaptation Mechanisms)": {
            "time_to_resolution": "2.5 months (until January 1, 2026)",
            "perspective_relevance": "As an expert in virology, specifically host adaptation mechanisms, my perspective is directly relevant to the IRAT's focus on emergence risk. The IRAT heavily weights factors such as human infections, transmission in animal models, receptor binding, population immunity, and genomic evidence of adaptation\u2014areas where understanding of viral adaptation to new hosts is critical. My expertise allows me to assess how likely H5 viruses are to acquire or have already acquired key mutations conferring efficient human-to-human transmission and sustained emergence potential.",
            "status_quo": "As of August 2024, the highest IRAT emergence risk for any H5N1 virus was 5.79 (moderate). No H5 virus has ever received a 'high' (>=8.0) emergence risk score. Historically, IRAT scores for H5N1 have remained moderate despite significant animal outbreaks and occasional zoonotic cases.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent Host Adaptation Mutations (PB2-478I and NP-450N)",
                    "effect": "Increases probability: These mutations in the North American H5N1 clade 2.3.4.4b have been shown to increase replication and pathogenicity in mammals, suggesting ongoing adaptation. However, evidence for efficient human-to-human transmission is still lacking."
                },
                {
                    "factor": "Zoonotic Infections and Transmission Pathways",
                    "effect": "Slightly increases probability: There have been 70 U.S. human cases (mostly mild, some unexplained), and the virus has now infected cattle, cats, and other mammals. However, no confirmed human-to-human clusters, and most cases remain occupational."
                },
                {
                    "factor": "IRAT Scoring Conservatism and Precedent",
                    "effect": "Decreases probability: The CDC has historically been cautious, requiring strong evidence of pandemic potential for a 'high' score. Even with notable adaptation events, IRAT scores for H5 have not breached the high threshold."
                },
                {
                    "factor": "Animal Model Transmission Data",
                    "effect": "Neutral/slightly decreases probability: While ferret studies show contact transmission and high virulence, airborne transmission (a key for human emergence) has not been demonstrated with current U.S. H5N1 genotypes."
                },
                {
                    "factor": "Surveillance and Reporting Lag",
                    "effect": "Decreases probability: Even if a virus acquires high-risk features, the IRAT process, publication, and CDC risk communication often lag real-time events, making a formal 'high' rating before Jan 1, 2026 less likely unless a dramatic event occurs."
                },
                {
                    "factor": "Base Rate of IRAT 'High' Ratings",
                    "effect": "Strongly decreases probability: No animal-origin influenza A virus has ever received a 'high' emergence risk score before; the base rate is essentially zero."
                }
            ],
            "no_scenario": "Despite ongoing outbreaks in animals and sporadic human infections, H5N1 remains poorly adapted for human-to-human transmission. The CDC continues to monitor the situation, but IRAT scores remain in the moderate range due to lack of evidence for efficient human transmission, no major new adaptation events, and cautious CDC risk communication.",
            "yes_scenario": "A major event occurs: either a cluster of confirmed human-to-human H5N1 transmission is detected (e.g., in a family or community setting), or clear evidence emerges of airborne transmission in ferrets or other relevant models, accompanied by genomic changes known to confer human adaptation. In response, the CDC rapidly updates its IRAT assessment, pushing the score to 8.0 or higher before Jan 1, 2026.",
            "final_reasoning": "While the host adaptation situation is evolving\u2014with concerning mutations (PB2-478I, NP-450N), mammalian spillover (notably cattle and cats), and rare unexplained human cases\u2014there remains no confirmed efficient human-to-human spread, no airborne transmission in animal models, and no IRAT precedent for a 'high' score. The IRAT system is conservative and has never rated an H5 virus as 'high' emergence risk, even during major global outbreaks. Furthermore, the time window is tight (2.5 months), and CDC updates typically lag behind both scientific discovery and outbreak events. Given the history, current evidence, and CDC's cautious approach, the base rate strongly favors a 'No' outcome. I do not discount the possibility of a major event, but the probability remains low unless there is a sudden, dramatic shift in the epidemiology or virological data.",
            "final_probability": 8
        },
        "Public Health Policy (Pandemic Risk Assessment Methods)": {
            "time_to_resolution": "Approximately 2.5 months (until January 1, 2026)",
            "perspective_relevance": "As an expert in public health policy and pandemic risk assessment, I bring deep knowledge of the CDC's IRAT methodology, zoonotic influenza evolution, and the multi-factorial triggers that drive risk scoring changes. My expertise enables me to weigh genetic, epidemiological, and policy factors that influence the probability of an H5 virus being rated 'high' emergence risk in the near term.",
            "status_quo": "No H5 virus has ever received a 'high' (>=8.0) emergence risk rating by the CDC IRAT. As of August 2024, the latest H5 IRAT emergence score was 5.79 (moderate). Historically, the IRAT scores change slowly, and high-risk designations are rare.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent Mammalian Adaptation and Outbreaks",
                    "effect": "Increases probability moderately. The detection of H5N1 in dairy cattle, with over 1,000 herds affected and at least 70 US human cases (mostly mild), and identification of mammalian-adaptive mutations (PB2-478I, NP-450N) increase concern. However, current evidence suggests limited to no efficient human-to-human transmission."
                },
                {
                    "factor": "IRAT Scoring Criteria and Historical Conservatism",
                    "effect": "Decreases probability. The IRAT tool scores are based on multiple elements (transmission, immunity, severity, etc.) and have historically been conservative, requiring strong, direct evidence of sustained human adaptation or transmission to cross the high-risk threshold. No H5 virus has yet reached 8.0, even after significant zoonotic events."
                },
                {
                    "factor": "Human Case Epidemiology",
                    "effect": "Neutral to slightly increasing. While the number of human H5N1 infections in the US has risen, cases are rare, mostly mild, and with little evidence of human-to-human transmission. One case in California had no clear animal exposure, but no onward transmission was detected. This raises concern but does not yet trigger IRAT high-risk change."
                },
                {
                    "factor": "Virological Evidence of Human Adaptation",
                    "effect": "Decreases probability. Despite mutations increasing mammalian virulence, studies show the bovine H5N1 retains avian-like receptor binding and does not transmit via airborne route in ferrets\u2014critical criteria for IRAT high emergence risk."
                },
                {
                    "factor": "Pandemic Surveillance and Policy Pressure",
                    "effect": "Slightly increases probability. The salience of H5N1 in public, political, and One Health contexts may create incentive for more aggressive risk communication or upward revision, especially with mounting One Health pressures. Yet, the CDC has historically resisted such shifts absent clear evidence."
                },
                {
                    "factor": "Base Rate of IRAT High Ratings",
                    "effect": "Strongly decreases probability. No H5 virus has ever reached the 8.0 threshold, and even the highest non-H1N1 IRAT emergence scores have plateaued below 7, suggesting high inertia."
                },
                {
                    "factor": "Time Remaining Until Resolution",
                    "effect": "Slightly decreases probability. With less than 3 months to go, a sudden re-evaluation would likely require a triggering event (e.g., cluster of efficient human-to-human transmission) that has not yet occurred."
                }
            ],
            "no_scenario": "Through December 2025, H5N1 continues to cause sporadic outbreaks in animals and rare, mostly mild, human spillover cases. Surveillance detects a few unexplained human cases, but there is no sustained transmission, no large clusters, and no major change in the virus\u2019s receptor binding or airborne transmissibility. The CDC updates IRAT scores, but the overall emergence risk for H5N1 remains moderate (<8.0), with risk communication emphasizing vigilance but not imminent pandemic threat.",
            "yes_scenario": "Before January 1, 2026, a significant shift occurs: either a cluster of H5N1 human cases with confirmed efficient human-to-human transmission emerges, or robust virological evidence is published showing the virus has acquired key molecular adaptations for airborne transmission between mammals (e.g., new receptor binding, airborne ferret transmission, or repeated unexplained non-occupational human cases). The CDC, in response to these developments and increased international concern, revises the IRAT emergence risk score for an H5 virus to 8.0 or higher.",
            "final_reasoning": "The base rate for an H5 virus receiving a high IRAT emergence score is extremely low\u2014no precedent in 10+ years of IRAT history. The most recent IRAT emergence risk for H5N1 is 5.79 (moderate), and no public evidence since June 2024 suggests a step change in human transmissibility. Despite growing concern about mammalian adaptation (notably in cattle) and a few unexplained human cases, there is no evidence of efficient or sustained human-to-human transmission, nor of a major shift in viral phenotype that would meet IRAT\u2019s high-risk criteria. The CDC is methodologically conservative, and the time window for a major scoring change is short. While one can envision a sudden event triggering a high-risk rating, the probability remains low absent such a development. I estimate the likelihood at 6%, reflecting a small risk of a last-minute virological or epidemiological breakthrough, but giving strong weight to the status quo and historical IRAT scoring inertia.",
            "final_probability": 6
        },
        "Public Health Policy (PREVENT Pandemic Preparedness)": {
            "time_to_resolution": "Approximately 2.5 months (until January 1, 2026)",
            "perspective_relevance": "As a public health policy expert focused on PREVENT pandemic preparedness, I am attuned to both epidemiological indicators and the institutional/operational triggers that lead to changes in official risk ratings. This includes understanding the IRAT\u2019s criteria, the threshold for a 'high' emergence risk (\u22658.0), and the CDC\u2019s cautious, evidence-driven approach. My expertise allows me to critically assess not just virological trends but also policy and bureaucratic inertia, surveillance capacity, and the interplay between scientific findings and risk communication.",
            "status_quo": "Historically, no H5 virus has received an IRAT 'high' emergence risk rating (\u22658.0). The latest published H5 IRAT emergence risk score is 5.79 (moderate risk), and the highest for any virus in recent years is 7.5 (H1N1, 2020). CDC and global agencies currently consider the public threat from H5N1 to be low to moderate, with no sustained human-to-human transmission documented.",
            "perspective_derived_factors": [
                {
                    "factor": "Recent H5N1 Mammalian Adaptation and Outbreaks",
                    "effect": "Increases probability. The appearance of mammalian-adaptive mutations (PB2\u2011478I and NP\u2011450N), outbreaks in cattle, and occasional spillover to humans suggest increased zoonotic potential and surveillance focus. However, no evidence of efficient human-to-human transmission yet."
                },
                {
                    "factor": "IRAT Scoring Criteria and CDC Caution",
                    "effect": "Decreases probability. The IRAT requires not just evidence of mammalian adaptation but also clear demonstration of human-to-human transmissibility, which is lacking. The CDC historically moves slowly and conservatively with rating upgrades, especially for 'high' emergence risk."
                },
                {
                    "factor": "Human Case Data and Transmission Evidence",
                    "effect": "Decreases probability. U.S. human cases remain rare (\u224870), mostly mild, and almost all linked to direct animal exposure, with no onward transmission confirmed. The CDC and WHO continue to rate general public risk as low."
                },
                {
                    "factor": "Surveillance, Awareness, and Scientific Uncertainty",
                    "effect": "Slightly increases probability. Enhanced surveillance, unexplained sporadic urban cases (e.g., San Francisco child), and growing scientific concern about environmental transmission may prompt CDC to reevaluate risk, especially if more unexplained or severe cases emerge."
                },
                {
                    "factor": "Pandemic Policy Incentives and External Pressure",
                    "effect": "Marginally increases probability. Heightened global attention, funding for countermeasures, and policy/institutional incentives could increase pressure to update risk ratings if new evidence emerges, but CDC is likely to resist unless criteria are clearly met."
                }
            ],
            "no_scenario": "Despite ongoing H5N1 outbreaks in animals (including mammals), and occasional human spillover, the virus does not acquire the necessary mutations for efficient, sustained human-to-human transmission. Human cases remain rare, mild, and linked to direct animal exposure. No cluster of unexplained or severe human cases emerges, and the CDC maintains the IRAT emergence risk rating for H5 below 8.0 (moderate or lower), citing insufficient evidence for a 'high' risk categorization.",
            "yes_scenario": "A sudden shift occurs: a cluster of unexplained or severe human H5N1 infections is detected, possibly with evidence of limited human-to-human transmission (e.g., household, nosocomial, or community spread). Genomic analysis identifies additional mammalian-adaptive mutations, and/or animal model data show efficient airborne transmission. The CDC IRAT panel, responding to new data and global pressure, upgrades the emergence risk rating for at least one H5 virus to 'high' (\u22658.0) before January 1, 2026.",
            "final_reasoning": "The baseline for an H5 virus being rated 'high' emergence risk by IRAT is extremely low: no precedent, and moderate risk (5.79) is the current status. While the North American H5N1 clade has accumulated mutations that increase mammalian pathogenicity, and there have been worrying signals (dairy cattle outbreaks, rare unexplained human cases), there is still no firm evidence of sustained human-to-human transmission\u2014a core IRAT criterion. The CDC and global partners continue to rate general public risk as low, and the IRAT panel is institutionally conservative. The recent scientific findings and sporadic unexplained cases nudge probability upward, but not enough to surmount the high bar for a 'high' rating. Only a dramatic virological or epidemiological development in the next 2.5 months\u2014such as confirmed clusters of human transmission or major new mutations\u2014would likely trigger reclassification. Given the short time window and the CDC's slow-moving process, the probability remains low, though not zero, and is slightly above strict base rate due to the current heightened alert and ongoing evolution of the virus.",
            "final_probability": 8
        }
    },
    "deliberation_probability": [
        6,
        7,
        7,
        8,
        7,
        8,
        8,
        6,
        8
    ],
    "deliberation_mean_probability": 7.222222222222222,
    "deliberation_sd": 0.8333333333333334,
    "deliberation_probability_result": 7
}